Memory decline is accompanied by pathological features in the brain of AD patients, including accumulation of extracellular amyloid plaques composed of β-amyloid (Aβ) peptides and intracellular neurofibrillary tangles (NFTs) formed by aggregated hyperphosphorylated microtubule-associated protein tau. The gene discussed is MAPT; the disease is Alzheimer disease.